CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

With global spending on prescription drugs increasing by 6% annually since 2019, it’s no surprise that the biopharmaceuticals industry is growing—and it’s expected to keep growing ...